These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 35567358)

  • 1. Analytical and clinical performance evaluation of a new high-sensitivity cardiac troponin I assay.
    Yang S; Zhang Q; Yang B; Li Z; Sun W; Cui L
    Clin Chem Lab Med; 2022 Jul; 60(8):1299-1307. PubMed ID: 35567358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Performance evaluation of a novel high-sensitivity cardiac troponin T assay: analytical and clinical perspectives.
    Li Z; Yang S; Qiao J; Tan Y; Liu Q; Yang B; Feng W; Cui L
    Clin Chem Lab Med; 2024 Apr; 62(5):979-987. PubMed ID: 37999934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the analytical and clinical performance of a new high-sensitivity cardiac troponin I assay: hs-cTnI (CLIA) assay.
    Li L; Shu X; Zhang L; Xu A; Yang J; Jing Y; Wang H; Zhang Z
    Clin Chem Lab Med; 2024 Jan; 62(2):353-360. PubMed ID: 37746851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay.
    Krintus M; Kozinski M; Boudry P; Capell NE; Köller U; Lackner K; Lefèvre G; Lennartz L; Lotz J; Herranz AM; Nybo M; Plebani M; Sandberg MB; Schratzberger W; Shih J; Skadberg Ø; Chargui AT; Zaninotto M; Sypniewska G
    Clin Chem Lab Med; 2014 Nov; 52(11):1657-65. PubMed ID: 24897400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation and Comparison with Other High-Sensitivity Methods of Analytical Performance and Measured Values of a New Laboratory Test for Cardiac Troponin I Assay.
    Masotti S; Musetti V; Prontera C; Storti S; Passino C; Clerico A
    J Appl Lab Med; 2021 Sep; 6(5):1237-1250. PubMed ID: 33829255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the new Beckman Coulter Access hsTnI: 99th percentile upper reference limits according to age and sex in the Korean population.
    Kim S; Yoo SJ; Kim J
    Clin Biochem; 2020 May; 79():48-53. PubMed ID: 32059836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. External validation of the 0/1h-algorithm and derivation of a 0/2h-algorithm using a new point-of-care Hs-cTnI assay.
    Koechlin L; Boeddinghaus J; Lopez-Ayala P; Wildi K; Nestelberger T; Wussler D; Guzman Tacla CA; Holder T; Muench-Gerber T; Glaeser J; Sanchez AY; Miró Ò; Martin-Sanchez FJ; Kawecki D; Buergler F; Buser A; Huré G; Giménez MR; Keller DI; Christ M; Mueller C;
    Am Heart J; 2024 Feb; 268():104-113. PubMed ID: 38042459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Determination of sex-specific 99th percentile upper reference limits for a point of care high sensitivity cardiac troponin I assay.
    Apple FS; Schulz K; Schmidt CW; van Domburg TSY; Fonville JM; de Theije FK
    Clin Chem Lab Med; 2021 Aug; 59(9):1574-1578. PubMed ID: 34022125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic performance of a high-sensitivity cardiac troponin I assay in patients with non-ST-elevation acute coronary syndrome.
    Bohula May EA; Bonaca MP; Jarolim P; Antman EM; Braunwald E; Giugliano RP; Newby LK; Sabatine MS; Morrow DA
    Clin Chem; 2014 Jan; 60(1):158-64. PubMed ID: 24052087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No increase in the incidence of cardiac troponin I concentration above the 99th percentile by Siemens Centaur high-sensitivity compared to the contemporary assay.
    Yang HS; Shemesh A; Li J; Xie T; Apple FS; Williams J; Zhao Z; Steel PAD
    Clin Biochem; 2021 Mar; 89():77-80. PubMed ID: 33296707
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fast 0/1-h algorithm for detection of NSTEMI: are current high-sensitivity cardiac troponin assays fit for purpose? An EQA-based evaluation.
    van der Hagen EAE; Cobbaert CM; Meijer R; Thelen MHM
    Clin Chem Lab Med; 2019 Nov; 57(12):1999-2007. PubMed ID: 31326959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analytical characterization and clinical performance evaluation of a new point-of-care testing system for high-sensitivity cardiac troponin I assay.
    Zhang R; Hong Y; Shi J; Zhao R; Song Y; Li Z; Wang Q
    Ann Clin Biochem; 2021 Nov; 58(6):579-585. PubMed ID: 34120481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myocardial Injury Thresholds for 4 High-Sensitivity Troponin Assays in U.S. Adults.
    McEvoy JW; Tang O; Wang D; Ndumele CE; Coresh J; Christenson RH; Selvin E
    J Am Coll Cardiol; 2023 May; 81(20):2028-2039. PubMed ID: 37197846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethnicity and sex-specific 99th percentile upper reference limits of high-sensitivity cardiac troponin I among adults in Xinjiang, China.
    Liu C; Deng Z; Wu W; Li Y; Yang F; Ge R; Ge M; Niu S; Liu H; Ji L; Li X; Huang X; Yusufu D; Zhang X
    Clin Biochem; 2023 Jun; 116():94-99. PubMed ID: 37084997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of Age- and Sex-Specific 99th Percentile Upper Reference Limits for High-Sensitivity Cardiac Troponin I in Healthy Chinese Adults.
    He B; Wang K; Xu P; Zhou Q; Xu J
    Cardiology; 2022; 147(3):261-270. PubMed ID: 35220311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transitioning high sensitivity cardiac troponin I (hs-cTnI) into routine diagnostic use: More than just a sensitivity issue.
    Lee GR; Browne TC; Guest B; Khan I; Murphy E; McGorrian C; Mahon NG; Fitzgibbon MC
    Pract Lab Med; 2016 Apr; 4():62-75. PubMed ID: 28856194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical performance and clinical decision limit of a new release for cardiac troponin I assay.
    Moretti M; Pieretti B; Sisti D; Rocchi M; Gasperoni S
    Ann Clin Biochem; 2015 Jan; 52(Pt 1):169-72. PubMed ID: 24711561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point-of-Care: Roadmap for Analytical Characterization and Validation of a High-Sensitivity Cardiac Troponin I Assay in Plasma and Whole Blood Matrices.
    Christenson RH; Frenk LDS; de Graaf HJ; van Domburg TSY; Wijnands FPG; Foolen HWJ; Kemper DWM; Bruinen AL; Meijering BDM; Fonville JM; de Theije FK
    J Appl Lab Med; 2022 Jun; 7(4):971-988. PubMed ID: 35660917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Direct comparison of clinical decision limits for cardiac troponin T and I.
    Kimenai DM; Henry RM; van der Kallen CJ; Dagnelie PC; Schram MT; Stehouwer CD; van Suijlen JD; Niens M; Bekers O; Sep SJ; Schaper NC; van Dieijen-Visser MP; Meex SJ
    Heart; 2016 Apr; 102(8):610-6. PubMed ID: 26794233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trial design for assessing analytical and clinical performance of high-sensitivity cardiac troponin I assays in the United States: The HIGH-US study.
    Christenson RH; Peacock WF; Apple FS; Limkakeng AT; Nowak RM; McCord J; deFilippi CR
    Contemp Clin Trials Commun; 2019 Jun; 14():100337. PubMed ID: 30834354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.